BioReference Laboratories

Saladax Biomedical, Inc, based in Bethlehem, PA, is revolutionizing psychiatry and oncology with rapid therapeutic drug monitoring assays. Their cutting-edge technology delivers rapid blood levels of commonly prescribed drugs, empowering healthcare providers to optimize patient care and make informed decisions about therapeutic interventions. As a pioneer in the field, Saladax is dedicated to enhancing patient outcomes by developing, manufacturing, and marketing innovative TDM assays for use in clinical laboratories or at point of care. Their assays play a pivotal role in providing real-time insights that minimize risks of suboptimal drug dosing or toxicities, ultimately transforming day-to-day clinical decisions for patients in the United States, Canada, Europe, and the Middle East. Generated from the website

EMSL Analytical Inc. is one of the leading environmental testing firms in the United States. Its network of nationwide laboratories has been providing quality analytical services since 1981. The firm offers a wide array of analytical testing services to support environmental investigations focused on asbestos, microbiology, lead paint, environmental chemistry, indoor air quality, industrial hygiene and food testing. Additionally, EMSL Analytical Inc. provides materials testing, characterization, and forensic laboratory services for a wide range of commercial, industrial, regulatory and law enforcement clients.

BioNanoTech is a pioneering company in Lawrence Township, NJ, that is revolutionizing the field of drug discovery and production. With their cutting-edge technology, they have developed the only technology capable of purifying proteins and antibodies across all size ranges, effectively turning waste into profit and accelerating the discovery of new cures. By capturing never-before-purified proteins with their innovative resins, BioNanoTech significantly reduces additional processing stages, providing ultra-high purity and unmatched capacity. Their groundbreaking technology eliminates the need to shelve drug and therapy candidates that are difficult or slow to purify, empowering companies to transform their existing protein antibody processes with greater quality and reduced lifetime costs.Generated from the website